Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
Vincasar PFS
Known as:
PFS, Vincasar
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Vincristine
Vincristine Sulfate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Prognostic role of PET/CT in endometrial cancer.
A. Yanarateş
,
E. Budak
Ginekologia Polska
2019
Corpus ID: 203850768
OBJECTIVES The present study evaluates the prognostic value of metabolic parameters related to the primary tumor identifiedin…
Expand
2018
2018
Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with…
C. Ostheimer
,
C. Evers
,
M. Bache
,
T. Reese
,
D. Vordermark
Strahlentherapie und Onkologie (Print)
2018
Corpus ID: 21733275
BackgroundThe urokinase plasminogen activator system (uPA, uPAR, PAI‑1) is upregulated in cancer and high plasma levels are…
Expand
2017
2017
Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.
Hiroki Ishihara
,
T. Kondo
,
+4 authors
K. Tanabe
Urologic oncology
2017
Corpus ID: 35508756
2017
2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia ‐ A Retrospective…
M. van Gelder
,
D. Ziagkos
,
+25 authors
J. Schetelig
Clinical Lymphoma, Myeloma & Leukemia
2017
Corpus ID: 34899684
2016
2016
Efficacy and safety of gefitinib and potential prognostic value of soluble EGFR, EGFR mutations, and tumor markers in a Gynecologic Oncology Group phase II trial of persistent or recurrent…
K. Leslie
,
M. Sill
,
+7 authors
N. Maihle
Journal of Clinical Oncology
2016
Corpus ID: 24057712
e16542 Background: A phase II trial was performed to evaluate the efficacy and safety of gefitinib and to explore epidermal…
Expand
2015
2015
Assessment of the effects of sterilization methods on protein drug stability by elucidating decomposition mechanism and material analysis.
Koji Nakamura
,
Hideaki Kiminami
,
Arisa Yamashita
,
Y. Abe
,
Keisuke Yoshino
,
Shigeru Suzuki
International journal of pharmaceutics
2015
Corpus ID: 205330822
Review
2014
Review
2014
Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC).
G. Kristensen
,
P. Harter
,
+17 authors
A. Bois
2014
Corpus ID: 74388812
5556^ Background: N is an oral inhibitor of VEGFR, PDGFR, and FGFR. As reported earlier, in the AGO-OVAR12 trial, N compared to…
Expand
2013
2013
Trastuzumab plus capecitabine vs. lapatinib plus capecitabine in patients with trastuzumab resistance and taxane-pretreated metastatic breast cancer
L. Bian
,
Tao Wang
,
Shaohua Zhang
,
Zefei Jiang
Tumor Biology
2013
Corpus ID: 14278381
The purpose of this prospective, nonrandomized, controlled study was to compare the regimen of continuously administering…
Expand
2001
2001
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer
J. Schrama
,
J. Baars
,
M. Holtkamp
,
J. Schornagel
,
J. Beijnen
,
S. Rodenhuis
Bone Marrow Transplantation
2001
Corpus ID: 730859
The purpose of this study was to determine the feasibility and efficacy of multiple courses of high-dose cyclophosphamide…
Expand
1995
1995
Continuous infusion of acidified saline around the rat sciatic nerve produces thermal hyperalgesia
T. Maves
,
G. Gebhart
,
S. T. Meller
Neuroscience Letters
1995
Corpus ID: 11694511
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE